fbpx

Xtant Medical Holdings Inc

XTNT

$0.58

Closing

▲6.74%

1D

▲31.13%

YTD

XTNT

BBG001T6FJR5

Exchange

Sector

Market cap

$80.75M

Volume

1,266

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$80.75M

Analysts' Rating

STRONG BUY

Price Target (Mean)

2.25

Total Analysts

2

P/E

Operating Margin

-13.52%

Beta

0.36

Revenue Growth

11.66%

52 week high

$1.27

52 week low

$0.33

Div. Yield

%

EPS Growth

33.33

Company Profile

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.